However, other trials reported the association of hormone-resistance PCa and tumor relapse specimens with increased levels of SRC-1 and SRC-2, respectively (Gregory et al. 2001; Culig et al. 2004). This evidence concerns the gene NCOA2 and posterior cortical atrophy.